MoonLake Immunotherapeutics

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
4,610,071
Value ($000)
60,761
Weight
1.4%
2023 Q2 - 2025 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).